We have not reviewed the charts of United Therapeutics Corporation (UTHR) since Dec. 8, 2017 and then we had a long-term Point and Figure target of $175. Prices finally reached that long-term price target this year.
More from Investing
Look for more positioning on Tuesday ahead of two important economic reports.
The stock just tested the underside of the declining 50-day moving average.